Skip to content

Comparing the effectiveness of post-burn itchy skin treatment with cetirizine or gabapentin

Effectiveness of post-burn pruritus treatment with cetirizine and gabapentin – a comparative study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10393098
Enrollment
63
Registered
2022-05-30
Start date
2017-06-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of pruritus in post-burn patients Skin and Connective Tissue Diseases

Interventions

The study was conducted on patients with burns involving >15% total body surface area at the Burn Unit of KBTH. Severe thermal burn was clinically defined as a thermal burn involving >20% TBSA. Select

Sponsors

Ghana College of Physicians and Surgeons
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 16–65 years age (assessments with VAS will be difficult in children and the elderly) 2. Patients with burns involving >15% TBSA (TBSA <15 patients are not admitted for treatment. 3. Patients hospitalised for more than 7 days 4. Patients who are proficient in English, Akan or Ga

Exclusion criteria

Exclusion criteria: 1. Patients who undergo skin grafting involving 5% TBSA were excluded to maintain ‘pure’ cohort 2. Patients with co-morbidities including skin diseases, diabetes, chronic renal diseases, obstructive jaundice, pregnancy, etc. which by themselves caused itching 3. Patients who were septic 4. Patients with impaired cognitive ability 5. Patients with known hypersensitivity reactions

Design outcomes

Primary

MeasureTime frame
Itch (pain) measured using the visual analogue scale at baseline, day 3, day 7, and day 14

Secondary

MeasureTime frame
1. Insomnia measured using the Athens Insomnia Scale at baseline, day 3, day 7, and day 14 2. Depression measured using the Hospital Anxiety and Depression Scale (HADS) at baseline, day 3, day 7, and day 14

Countries

Ghana

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026